No diet/lifestyle, no pregnancy, no eating disorder, no race/ethnicity
If the test confirms your vendor is reliable, you have validated your entire supply chain for the cost of a single vial
A gradual taper rather than stopping cold turkey is generally recommended
Clinical trial integrity and manufacturing standards remain high priorities: Violations in GMP, IRB oversight, clinical-trial compliance, misbranding, and more remain top enforcement targets, underscoring the breadth of CDERs enforcement net
If your protocol included other research peptides alongside the GH secretagogues, you can explore our full peptide collection to understand which compounds require structured cessation versus which can be stopped abruptly without consequence
doi: 10.1038/s41467-019-14132-y